剂泰科技-P今日盘中大跌8.23%，引起了市场的广泛关注。
消息面上，剂泰科技作为全球AI药物递送第一股于近期登陆港交所，上市首日曾大幅上涨，但随后市场热度加速消退，股价进入连续回调阶段。公司目前尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证，这给股价带来基本面压力。此外，部分国际配售股份未设置禁售期，导致上市后存在持续的获利了结压力，进一步加剧了股价的下跌。
综合来看，新股上市初期的炒作热情退潮、公司自身的盈利挑战以及股东套现压力，共同导致了剂泰科技-P此次盘中大幅下挫。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.